TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Panafarma Medical Consult AB
Closing information (x1000 SEK)
Closing information | 2023/06 | 2022/06 | 2021/06 |
Turnover |
300
|
383
|
345 |
Financial expenses |
0
|
2
![]() |
2 |
Earnings before taxes |
52
|
31
|
1 |
EBITDA |
52
|
32
|
4 |
Total assets |
367
|
457
|
462 |
Current assets |
366
|
455
|
460 |
Current liabilities |
118
|
199
|
172 |
Equity capital |
232
|
242
|
267 |
- share capital |
100
![]() |
100
![]() |
100 |
Employees (average) |
2
![]() |
2
![]() |
2 |
Financial ratios
Fiscal year | 2023/06 | 2022/06 | 2021/06 |
Solvency |
63.2%
|
53.0%
|
57.8% |
Turnover per employee |
150
|
192
|
172 |
Profit as a percentage of turnover |
17.3%
|
8.1%
|
0.3% |
Return on assets (ROA) |
14.2%
|
7.2%
|
0.6% |
Current ratio |
310.2%
|
228.6%
|
267.4% |
Return on equity (ROE) |
22.4%
|
12.8%
|
0.4% |
Change turnover |
-83
|
38
|
-131 |
Change turnover % |
-22%
|
11%
|
-28% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/06 | 2022/06 | 2021/06 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.